Vir Biotechnology Inc (VIR)

Vir Biotechnology Inc (VIR) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $1.8B; returns 1 day +1.3%, 1 week +6.1%, 1 year +82.9%.

Vir Biotechnology Inc. is a clinical-stage immunology company focused on discovering and developing novel medicines to treat and prevent serious infectious diseases and cancer. Its current strategy, following a pivot from pandemic-related revenue, centers on its robust pipeline, primarily targeting chronic hepatitis delta (CHD) and various solid tumors.

Groups VIR belongs to

• Clinical Stage Biotech
• Biotechnology
• Immunotherapy
• Healthcare
• Infectious Diseases
• Antibody Therapeutics
• Oncology
• Cancer Therapeutics
• Life Sciences
• Strategic Pivot

VIR financial model: income statement, cash flow and balance sheet